The reason I feel this NASH presentation is a big deal is nobody knows who we are. My guess is about 95% of the industry doesn't know about LL. During the Pandemic of the about 20 healthcare professionals dealing with the disease I met, none knew about leronlimab, none. We have always had a Major Media problem.

So here's a chance for the NASH world to find out about us and the fact that Pfizer helped a little company out is a very positive sign. If we have a potential partner, this will help lock down a deal and a better deal. And this isn't just about NASH, any potential partner from BP would want to look at other indications. Everyone is there to promote their drug in order to sell it. This is our first time to just sell Leronlimab and not go it alone trying to do everything. Remember, Leronlimab is the product, not CytDyn!